FDA Enjoins Pharmas From Selling Unapproved Drugs

Law360, New York (April 13, 2009, 12:00 AM EDT) -- The U.S. Food and Drug Administration has won a permanent injunction barring two pharmaceutical companies and their owners from manufacturing and selling unapproved drugs, after the companies and the administration agreed on a settlement.

The FDA announced Friday that Neilgen Pharmaceuticals Inc. and parent company Advent Pharmaceuticals Inc. signed off on a consent decree that will halt the companies' manufacture of drugs that have not been approved by the administration. The decree entered into force Thursday after being signed by Judge Benson Legg of the U.S....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.